Download Profile #78

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
Transcript
Profile #78
Profile #78 - Cukurova University - Turkey
Date: 2004/09/13
Deadline: 2010/12/30
Contact
Organisation
Cukurova University
Contact
person
Erbatur, Dr Oktay
Email
[email protected]
Address
Faculty of Science & Letters
Postcode
01330
Country
Turkey
Telephone
+90-322-338-6540
Website
http://www.cu.edu.tr
Department
Chemistry
City
Adana
Fax
+90-322-338-6070
Organisation
Type:
Research Organisation & Universities
Is a Small and Medium Sized Enterprise (SME)? NO
Number of
Employees
3000
Description of
research
activity:
Subject: Collaboration in FP6 of European Union
Contact Person:
Oktay Erbatur (Professor of Industrial & Analytical Chemistry)
Department of Chemistry
Cukurova University
01330 Adana
Turkey
Phone: +90-322-338 6540
Fax: +90-322-338 6070
e-mail: [email protected]
Topic 1:
Cloning and Expression of Feed Upgrading Enzymes in Spirulina sp.
Some beneficial enzymes may be clonned and expressed in microalgae, such as
lysozyme (immune stimulating and anti-bacterial enzyme) and phytase (fitat
degragating and P liberating enzyme; especially used to supplement feed and food
for creating less manure and reducing risk of environmental pollution. Recombinant
Spirulina sp (cyanobacterium) cells carrying such enzymes may be used
directly to feed animal, fish or indirectly for human consumption. Alternatively all
these enzymes may be isolated from Spirulina cell after harvesting the recombinant
cyanobacterium.
Currently, it is difficult to clone genes in Spirulina sp. because of lack of
transformation systems and available vectors for most of the microalgae including
the cyanobacterium spirulina. Therefore we are targeting now to develop gene
transfer systems and construction of a new vector for spirulina. After establishing
gene transfer and expression systems for spirulina, cultivation of recombinant
spirulina cells and extraction/developing enrichment techniques with respect to the
valuable enzyme and other health and nutritionally beneficial components will be
developed.
Type of FP6 Project:
STREP (The above topic is consistent with some of the priority topics to be
announced in the third call of Food Quality and Safety thematic area)
Partners Sought:
• One SME from any country experienced in microalgae production who will
produce newly developed Spirulina sp. cyanobacterium in pilot-plant scale in one of
the Mediterranean areas.
• One SME and/or one applied research group from food & nutrition research
institutes or universities from any country to develop new and innovative ready-toeat products and semi-prepared foodstuffs by using the extracts of newly developed
cyanobacterium and to carry out the relevant analysis and tests on these food
material.
Contact person of research groups aggreed to collaborate (no formal aggreement
yet) and the relevant research work they will be responsible:
Professor Avigad Vonshak, Ben-Gurion University of the Negev, Microalgal
Biotechnology Unit, 84105 Beer-Sheva, ISRAEL
(Please write here what you propose in one or two sentences)
Professor Numan Ozcan, Department of Zootechnology, Faculty of Agriculture,
Adana 01330, Turkey
Genetic transformations via enzyme cloning in Spirulina sp.
Assoc. Professor Oya Isik, Department of Marine Microbiology, Faculty of Fisheries
Adana 01330, Turkey
Production of newly developed Spirulina sp. strains in lab-scale greenhouse type of
structures under Mediterranean climate conditions.
Prof. Oktay Erbatur
Department of Chemistry, Faculty of Science & Letters, Cukurova University, Adana
01330, Turkey
Former participation in an FP European project? NO
Expertise/commitment offered
Keywords
specifying the
expertise:
Chemical processes under high pressure; supercritical fractionation
Description of the
expertise:
Complex plant constituents are extracted and in-situ fractionated under
supercritical conditions to obtain concentrated value-added health beneficial
products.
Commitment
offered
Research,Technology
Expectations
Term
commitment:
Medium (1 to 3 years)
Expected results
for your
organisation:
Developing technology for obtaining value-added health beneficial products